Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2023 | Precision medicine in pediatric ALL

Sarah Tasian • 4 Jun 2023
ASCO 2023
Acute Lymphoblastic Leukemia Leukemia

Sarah Tasian, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA, discusses precision medicine in the management of pediatric acute lymphoblastic leukemia (ALL), highlighting prognostic indicators such as cytogenetics and MRD status following induction chemotherapy. Dr Tasian follows by sharing strategies currently under evaluation such as targeted agents and immunotherapies. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sarah Tasian

The management of Ph-like ALL: moving towards an individualized precision medicine approach
2:00
The management of Ph-like ALL: moving towards an individualized precision medicine approach
Sarah Tasian • 3 Sep 2025
Diagnostic advances that could further individualize care in ALL
0:40
Diagnostic advances that could further individualize care in ALL
Sarah Tasian • 3 Sep 2025
How advances in molecular sequencing technologies have shaped ALL therapy
1:05
How advances in molecular sequencing technologies have shaped ALL therapy
Sarah Tasian • 3 Sep 2025
Pediatric leukemia at ASCO 2023
1:16
Pediatric leukemia at ASCO 2023
Sarah Tasian • 4 Jun 2023

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals